The stock of Hims & Hers Health Inc (NYSE:HIMS) last traded at $15.74, down -0.51% from the previous session.
HIMS stock price is now 36.23% away from the 50-day moving average and 82.92% away from the 200-day moving average. The market capitalization of the company currently stands at $3.37B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $16, Imperial Capital recently Upgraded its rating from In-line to Outperform for Hims & Hers Health Inc (NYSE: HIMS). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $10, while ‘Imperial Capital’ rates the stock as ‘In-line’
In other news, Dudum Andrew, Chief Executive Officer sold 50,361 shares of the company’s stock on Mar 20 ’24. The stock was sold for $823,055 at an average price of $16.34. Upon completion of the transaction, the Chief Executive Officer now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 20 ’24, Chief Financial Officer Okupe Oluyemi sold 9,912 shares of the business’s stock. A total of $156,816 was realized by selling the stock at an average price of $15.82. This leaves the insider owning 168,627 shares of the company worth $2.65 million. A total of 35.26% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $17.16. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 3.00, and a quick ratio of 2.74. The fifty day moving average price for HIMS is $11.70 and a two-hundred day moving average price translates $8.64 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for Dec, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.01, beating analysts’ expectations of -$0.02 by 0.03. This compares to -$0.05 EPS in the same period last year. The net profit margin was -2.70% and return on equity was -7.18% for HIMS. The company reported revenue of $246.62 million for the quarter, compared to $167.2 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 47.5 percent. For the current quarter, analysts expect HIMS to generate $270.5M in revenue.
